Photodynamic Therapy and Photodiagnosis in Clinical Practice October 2014 POSTER SESSION A A-1 Targeting pancreatic cancer by porphyrins P. Acedo (Stockholm, Sweden), R. Heuchel, A. Sznarkowska, J. Zawacka-Pankau A-2 The influence of chitosan-amphyphilic polymers mixture on the dimegin photosensitizing activity N. A. Aksenova (Moscow, Russia), V. V. Kardumjan, S. Z. Rogovina, N. N. Glagolev, A. B. Solovieva A-3 Synthesis and characterization of substituted chlorins and bacteriochlorins suitable to be anchored to nanoparticles for application in PDT M. L. Alagna, D. Perrone, E. Polo (Ferrara, Italy) A-4 Extramammary Paget’s disease of the perineum: PDT the treatment of choice E. Allan (Manchester, United Kingdom), D. Allan, L. Sheridan, S. Rimouche A-5 Ru(II)-based photodynamic inactivation (PDI) as an effective method against common nosocomial infections : an update on in-vitro results and in vivo, a murine model of infected-wound sepsis, data Y. Arenas, G. Fila, A. Mandel, J. Nakonieczna, L. Lilge A-6 Photophysical properties of «porphyrins – ruthenium complexes» for potential PDT applications P. Arnoux, Myrzakhmetov B., Panfilov S., C. Frochot (Nancy, France), Beley M., Lachaud F., Gros P., Ruppert R. A-7 Preparation, characterization and evaluation of antibacterial activity of different liposomal formulations containing a novel porphyrin derivative S. Arpicco (Torino, Italy), V. Tinetto, R. Lorenzi, B. Rolando, S. Del Piero, L. Guidolin, R. Fruttero, G. Jori, A. Gasco B B-1 Control of the population of Diptera as vectors of the causative agents of malaria and Dengue fever by environmentally friendly photodynamic processes S. Bramuzzo (Padova, Italy), S. Del Piero, M. Camerin, G. Jori, L. Guidolin, O. Coppellotti C C-1 Preliminary data of bimodal cancer therapy using functionalized photoactivatable nanoparticles M. Camerin (Padova, Italy), A. Fraix, M. Ballestri, G. Jori, P. Irato, G. Sotgiu, G. Varchi, I. Manet, S. Sortino, O. Coppellotti C-2 Treatment of chronic venous ulcers with PDT: new results about immunopathological aspects A. Corsi (Firenze, Italy), P. P. Lecci, S. Bacci, N. Pimpinelli, I. Ruffinno, A. Cappuccini, F. Nocentini, G. Puppo, P. Cappugi, H. Martini D D-1 Understanding the factors that determine cures in photoimmunotherapy from the performance of a novel modified bacteriochlorin J. M. Dabrowski (Krakow, Poland), M. Krzykawska, L. B. Rocha, K. Urbańska, G. Stochel, L. G. Arnaut 2014 D-2 Use of heterogeneous photodynamic sensitization as a tool for the prevention of waterborne diseases S. Del Piero (Padova, Italy), Bramuzzo S., Camerin M., Jori G., L. Lazzarato, S. Guglielmo, R. Fruttero, S. Arpicco, Coppellotti O., Guidolin L. D-3 Repeated low-dose Pba/PDT treatments stimulate cell growth of prostate cancer cells E. Della Pietra (Udine, Italy), D. Cesselli, B. Bonavida, L. E. Xodo, V. Rapozzi D-4 Fluorescence and photodynamic diagnosis with topical application of 5-aminolevulinic acid in oral diseases, clinical cases A. Dojs (Gorzów Wlkp, Poland), A. Graczyk, K. Opalko, M. Dojs D-5 Peptide-targeted photosensitisers via efficient ‘click’ conjugation in solution R. Dondi, E. Yaghini, M. Loizidou, A.J. MacRobert, I. M. Eggleston (Bath, United Kingdom), D-6 Strategies for the design of photosensitizing phthalocyanines with NIR-shifted maximum absorption F. Dumoulin (Gebze, Kocaeli, Turkey) D-7 Amphiphilic and halogenated porphyrins for optimized cell uptake and singlet oxygen generation F. Dumoulin (Gebze, Kocaeli, Turkey), D. Lafont, F. Poyer, P. Maillard, G. Garcia, D. Topkaya E-1 Fast and effective inactivation of multiresistant bacteria by light activated riboflavin derivatives A. Eichner (Regensburg, Germany), T. Maisch, A. Späth, A. Gollmer, B.König, J. Regensburger, E. Kowalewski, W. Bäumler F-1 Applicability of new degradable hypericin-polymer-conjugates as photosensitizers: principle mode of action demonstrated by in-vitro models D. Feinweber, T. Verwanger, O. Brüggemann, I. Teasdale, Barbara Krammer (Salzburg, Austria) F-2 Increasing the Therapeutic Index of PDT with Hypothermia C. Fisher, C. Niu, W.Foltz, Y. Chen, L. Lilge (Toronto, Canada) F-3 The influence of photodynamic therapy on VEGF secretion of colon cancer cells in hypoxic conditions B. Flak (Bytom, Poland), A. Kawczyk‐Krupka, Z. Czuba, W. Latos, S. Kwiatek, K. Wawrzyniec, A. Mertas, W. Król, A. Sieroń G-1 Synthesis of platforms combining porphyrin and peptides via click chemistry technique A. M. Gazzali, A. Stallivieri, B. Myrzakhmetov, M. Achard, P. Arnoux, S. Acherar, C. Frochot, R. Vanderesse (Nancy, France) G-2 New water soluble porphyrins and their metal-conjugates for PDT applications T. Gianferrara, G. Mion (Trieste, Italy), A. Bergamo, G. Gasser, V. Pierroz, E. Alessio G-3 Glioma rat cancer studies using PCI technology O. A. Gederaas (Trondheim, Norway), A. Hauge, P. Ellingsen, K. Berg T. Bardal, A. Høgset, M. Lindgren E F G H H-1 K K-1 Photodynamic Therapy of airway-obstructing non small cell lung cancer with Fotolon® - first results D. Hüttenberger (Bielefeld, Germany), S. Herkner-Güthaus, K. Darwische, L. Freitag, M. Haupt Biophysical, in vitro, ex vivo, and in vivo evidence for the efficacy of three novel Os(II) based photosensitizers in photodynamic therapy mediated by visible (400-750 nm) and NIR (810 nm) wavelengths P. Kaspler, S. Lazic, Y. Arenas, J. Fong, K. Kasimova, A. Mandel, L. Lilge (Toronto, Canada) 2014 K-2 Analysis of approval review reports for PDT regulatory approval in Japan and the USA Y. Kawase (Yokohama, Japan), H. Iseki K-3 The influence of photodynamic therapy on macrophage migration inhibitory factor (MIF) and monocyte chemotactic protein (MCP-1) secretion by colon cancer cells in hypoxic environment A. Kawczyk-Krupka (Bytom, Poland), K. Wawrzyniec, W. Latos, P. Oleś, B. Flak, S. Kwiatek, A. Mertas, Z. Czuba, W. Król, A. Sieroń K-4 Autofluorescence imaging of precancerous and cancerous tissues S. Kwiatek (Bytom, Poland), W. Latos, A. Kawczyk–Krupka, B. Kwiatek, A. Sieron K-5 5-ALA induced fluorescence for identification of intracranial lymphomas in stereotactic biopsies B. Kiesel (Vienna, Austria), M, Millesi, S. Wolfsberger, E. Knosp, G. Widhalm L-1 The role of photodynamic diagnostic in gastrointestinal diseases - 20 years experiences W. Latos (Bytom, Poland), A. Kawczyk–Krupka, S. Kwiatek, B. Flak, K. Sieroń-Stołtny, A. Sieron L M M-1 Optical spectroscopy for stereotactic biopsy of brain tumours N. Markwardt (München, Germany), A. von Berg, W. Beyer, D. Brucker, A. Ehrhardt, S. Fiedler, S. Fischer, W. Goebel, M. Goetz, G. Hennig, J. Herms, K.-M. Irion, A. Johansson, P. Li, G. Kniebühler, C. Polzer, A. Rühm, S. Sandner, H. Stepp, P. Zelenkov M-2 Uptake of porphycenes by cells in different carrier media N. Masiera (Warsaw, Poland), H. Piwoński, A. Bojarska, I. Gawryszewska, J. Waluk O O-1 The effect of bovine serum albumin on photophysical and photochemical properties of WST11 T. Oles, I. Pinkas, A. Scherz, J. Moscicki, T. Sarna (Krakow, Poland) O-2 Sonochemical internalization enhances the cytotoxic effect of bleomycin T. Osaki (Tottori, Japan), I. Yokoe, Y. Uto, M. Ishizuka, T. Tanaka, N. Yamanaka, T. Kurahashi, K. Azuma, Y. Murahata, T. Tsuka, N. Ito, T. Imagawa, Y. Okamoto O-3 Modification of photodynamic therapy using an inhibitor of cholesterol synthesis on a model of colon cancer in vitro B. J. Osiecka, M. Woźniak, K. Symonowicz (Wrocław, Poland) R R-1 Singlet oxygen in solid states – Photophysics in polymers J. Regensburger, Lorenz S., Wennige S., Maisch T., Felgenträger A. (Regensburg, Germany) R-2 Dosimetric parameters impact the durability of photodynamic destruction of multifocal nodules in a 3D tumour model I. Rizvi, S. Anbil, N. Alagic, J. P. Celli, L. Z. Zheng, A. Palanisami, M. Glidden, B. Pogue, T. Hasan (Boston, MA, USA) R-3 Developing PDT-based combination regimens to target physical and stromal determinants of ovarian cancer biology in bioengineered models I. Rizvi, U. Gurkan, S. Tasoglu, N. Alagic, L. Mensah, Z. Mai, J. Celli, M. Glidden, S. Anbil, U. Demirci, T. Hasan (Boston, MA, USA) R-4 Ingestible capsule for the treatment of Helicobacter pylori infection G. Romano (Firenze, Italy), B. Orsini, F. Cubeddu, G. Tortora, M. Monici, E. Surrenti, A. Menciassi, C. Surrenti, F. Fusi R-5 Optical monitoring and individualization of 5-ALA based photodynamic therapy of glioblastoma to improve treatment outcomes A. Rühm (München, Germany), H. Stepp, W. Beyer, M. Hermwille, J. Rudrof, G. Hennig, T. Pongratz, R. Sroka, Oliver Schnell, J. C. Tonn, F.-W. Kreth, 2014 S S-1 Photodynamic inactivation of Leishmania major parasites by SAPYR M. Schmid, A. Hurst, K. Stricker, T. Mayer, F. Grünberger, A. Späth, S. Thalhauser, W. Bäumler, T. Maisch, U. Ritter (Regensburg, Germany) S-2 Photodynamic diagnosis and therapy in clinical practice A. Sieroń (Bytom, Poland ), W. Latos, S. Kwiatek, B. Flak, K. Wawrzyniec, A. Kawczyk-Krupka S-3 Chlorin e6-assisted photodynamic inactivation of Helicobacter pylori: lab and patient strains C. Simon, C. Mohrbacher, N. Betz, D. Hüttenberger, I. Bauer-Marschall, A. Stachon, H.-J. Foth S-4 Effect of fotoditazin-amphiphilic polymer complexes on early stage of the wound healing process against the background photodynamic therapy A. B. Solovieva (Moscow, Russia), T. G. Rudenko, N. N. Glagolev, N. N. Aksenova, S. F. Timashev S-5 Improving photodynamic inactivation of bacteria in dentistry: Highly effective and fast killing of oral key pathogens with novel tooth-colored type-II photosensitizers A. Späth (Regensburg, Germany), C. Leibl, F. Cieplik, K. Lehner, J. Regensburger, S. Wennige, K.-A. Hiller, W. Bäumler, G. Schmalz, T. Maisch S-6 Improvement of the selectivity of Photodynamic action with Photodynamic Molecular Beacons A. Stallivieri (Nancy, France), J. Devy, N. Etique, M. Achard, R. Vanderesse, M. Barberi-Heyob, C. Frochot S-7 Synthesis and characterization of Gadolinium nanosheets with bound rose bengal. Potential use in MRI and photodynamic therapy D. Stefanakis, S. Ioannis, D. Ghanotakis (Alexandroupolis, Greece) T-1 Optimization of illumination in interstitial photodynamic therapy for high-grade brain tumours M.Toussaint (Vandœuvre-lès-Nancy Cedex), M. Thomassin, M. Amouroux, E. Galbrun, W. Blondel, T. Bastogne, C. Frochot, S. Mordon, M. Barberi-Heyob V-1 Systemic immunity after vascular-targeted PDT by hypericin T. Verwanger, D. Rauch, P. Cantonati, B. Krammer (Salzburg, Austria) T V W W-1 Influence of sub-lethal doses of ALA-PDT on growth factors’ secretion by colon cancer cells in hypoxic environment K. Wawrzyniec, A. Kawczyk-Krupka, Z. Czuba, W. Latos, B. Flak, P. Oleś, S. Kwiatek, A. Mertas, W. Król, A. Sieroń2 W-2 Intraoperative visualization of intracranial meningiomas with 5-ALA induced fluorescence: experience in more than 200 procedures G. Widhalm (Vienna, Austria), M. Millesi, B. Kiesel, S. Wolfsberger, E. Knosp W-3 Photosensitised generation of singlet oxygen in silicone polymer substrates doped with methylene blue for antimicrobial applications J. H. Woodhams, M. J. Bovis, S. Noimark, A.-P. Correira, I. P Parkin, A. J. MacRobert Z Z-1 Natural carotenoids as potential singlet oxygen quenchers K. Zaghdoudi (Nancy, France), Y. Guiavarc’h, R. Kudaibergenova, B. Myrzakhmetov, A. Stallivieri, P. Arnoux, R. Vanderesse, C. Frochot Z-2 Dissecting the mechanism of porphyrin-mediated cancer cell death in dark and after photodynamic reaction J. Zawacka-Pankau (Stockholm, Sweden) 2014
© Copyright 2024 ExpyDoc